BIOMÉRIEUX Attività
- applicazioni mediche (84,4%): nell'industria, test microbiologici di campioni provenienti da prodotti finiti, materiali durante il processo di produzione o ambiente, principalmente nei settori alimentare, farmaceutico e cosmetico;
- applicazioni industriali (15,6%).
I sistemi diagnostici del Gruppo sono composti da tre elementi con servizi correlati: reagenti, strumenti (o piattaforme o analizzatori), software e servizi.
Le vendite nette sono distribuite geograficamente come segue: Europa/Medio Oriente/Africa (32,4%), Nord America (44,1), Asia/Pacifico (17,3%) e America Latina (6,2%).
Vendite per attività
| EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Clinical Applications
84,3
%
| 3 040 | 84,7 % | 3 099 | 84,3 % | +1,95% |
Industrial Applications
15,7
%
| 549 | 15,3 % | 575 | 15,7 % | +4,79% |
Vendite per regione
| EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Americas
50,2
%
| 1 841 | 51,3 % | 1 846 | 50,2 % | +0,26% |
EMEA
26,3
%
| 901 | 25,1 % | 965 | 26,3 % | +7,05% |
Asia Pacific
17,4
%
| 624 | 17,4 % | 638 | 17,4 % | +2,15% |
France
6,1
%
| 220 | 6,1 % | 226 | 6,1 % | +2,64% |
Corporate
0,0
%
| 3 | 0,1 % | 1 | 0,0 % | -65,38% |
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 01/11/16 |
| Chairman | 50 | 16/04/04 | |
| Director of Finance/CFO | 48 | 01/03/18 | |
Jennifer Zinn
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/23 |
| Director/Board Member | 74 | 15/09/06 | |
Valérie Leyldé
IRO | Public Communications Contact | - | - |
Yasha Mitrotti
PRN | Corporate Officer/Principal | - | - |
Sylvain Morgeau
PRN | Corporate Officer/Principal | 44 | 01/01/11 |
| Corporate Officer/Principal | 58 | - |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
| Director/Board Member | 74 | 15/09/06 | |
| Director/Board Member | 63 | 01/01/05 | |
| Chairman | 50 | 16/04/04 | |
| Director/Board Member | 59 | 30/05/12 | |
| Director/Board Member | 59 | 30/05/12 | |
Fanny Letier
BRD | Director/Board Member | 45 | 30/06/17 |
| Director/Board Member | 68 | 28/08/17 | |
Sylvain Orenga
BRD | Director/Board Member | - | 24/05/22 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 118 361 220 | 42 884 007 ( 36,23 %) | 206 987 ( 0,1749 %) | 36,23 % |
Partecipazioni
| Nome | Azioni | % | Valorizzazione |
|---|---|---|---|
| 59 062 832 | 6.85% | 80 688 097 $ | |
BIOMÉRIEUX 0.17% | 201 318 | 0.17% | 21 232 212 $ |
Coordinate società
Società del gruppo
| Nome | Categoria e settore |
|---|---|
bioMérieux CZ sro
 bioMérieux CZ sro Medical SpecialtiesHealth Technology Part of Compagnie Merieux Alliance SAS, bioMérieux CZ sro is a company based in Prague, Czechia. The Czech company manufactures laboratory equipment. |
Medical Specialties
|
bioMérieux China Ltd. (HongKong)
 bioMérieux China Ltd. (HongKong) Medical DistributorsDistribution Services Part of Compagnie Merieux Alliance SAS, bioMérieux China Ltd. (HongKong) is a company located in Hong Kong that wholesales and distributes surgical and medical instruments. |
Medical Distributors
|
bioMérieux Asia Pacific Pte Ltd.
| |
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. |
Medical Specialties
|
bioMérieux Sweden AB
| |
bioMérieux Italia SpA
 bioMérieux Italia SpA Medical SpecialtiesHealth Technology bioMérieux Italia SpA engages in research and development activities in the clinical diagnostics and industrial microbiology sectors. The firm focuses on treatments in the field of infectious diseases, cardiovascular emergencies, and targeted therapies for cancer. Its products and services also aim to prevent the risks of contamination in agri-food, pharmaceutical, and cosmetic products. The company was founded in 1985 and is headquartered in Bagno a Ripoli, Italy. |
Medical Specialties
|
Biofire Diagnostics, Inc.
 Biofire Diagnostics, Inc. Electronic Production EquipmentElectronic Technology Biofire Diagnostics, Inc. manufactures, markets and sales of the film array system. Its FilmArray is an FDA-cleared multiplex PCR system that integrates sample preparation, amplification, detection and analysis. The firm has three FDA cleared panels the respiratory Panel, the blood culture identification panel, and the Gastrointestinal Panel. The company was founded by Randy Rasmussen, Carl Wittwer and Kirk Ririe in 1990 and is headquartered in Salt Lake City, UT. |
Electronic Production Equipment
|
Applied Maths NV
 Applied Maths NV Packaged SoftwareTechnology Services Applied Maths NV develops software for the biosciences. It offers desktop software such as BioNumerics, GelCompar II, GeneMaths XT, and Kodon. It also offers server software such as BioNumerics server. The firm also offers services such as training workshops, on-site training, data analysis, and scripts development. The company was founded by Paul Vauterin and Luc Vauterin in 1992 and is headquartered in Sint-Martens-Latem, Belgium. |
Packaged Software
|
bioMérieux Mexico SA de CV
 bioMérieux Mexico SA de CV Medical SpecialtiesHealth Technology Part of Compagnie Merieux Alliance SAS, bioMérieux Mexico SA de CV is a microbiological testing solutions company based in Mexico City, Mexico. The Mexican company provides in vitro diagnostic solutions to the food and pharmaceutical industries to manufacture safe products and improve productivity levels. The company's solutions include reagents, instruments, software, and services that determine the source of disease and contamination to improve patient health and ensure consumer safety. |
Medical Specialties
|
Settore
Vendite per attività
Vendite per regione
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| -19,37% | 6,81 Mrd | |
| +6,63% | 5,74 Mrd | |
| +27,24% | 5,47 Mrd | |
| -21,19% | 3,59 Mrd | |
| +6,64% | 2,56 Mrd | |
| +30,09% | 2,25 Mrd | |
| -66,53% | 2,24 Mrd | |
| -12,28% | 2,21 Mrd | |
| -21,64% | 1,52 Mrd |
